A randomized, double-blind, three-way crossover drug interaction study of M 118, clopidogrel and aspirin.

Trial Profile

A randomized, double-blind, three-way crossover drug interaction study of M 118, clopidogrel and aspirin.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2008

At a glance

  • Drugs Adomiparin (Primary) ; Aspirin; Clopidogrel
  • Indications Cardiovascular disorders; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Sponsors Momenta Pharmaceuticals
  • Most Recent Events

    • 11 Aug 2008 New trial record.
    • 25 Jul 2008 Results presented at IXth World Conference on Clinical Pharmacology and Therapeutics Meeting, Quebec, Canada.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top